Inventor · disambiguated record
Thomas S. Kupper
Also filed as: KUPPER THOMAS · KUPPER THOMAS S
11 granted patents·6 pending applications·24 citations·filing 2000–2023
85Inventor score
Files withDANA FARBER CANCER INST INC6BRIGHAM & WOMENS HOSPITAL INC3KUPPER THOMAS S2ADAPTIVE BIOTECHNOLOGIES CORP1BRIGHAM & WOMENS HOSPITAL1
Top patents by PatentIndex Score
17 records- 0180US9441045B2Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2013·Granted Sep 13, 2016·2 cites·6 claims
- 0280US8691502B2T-cell vaccination with viral vectors via mechanical epidermal disruptionKUPPER THOMAS S·Filed 2011·Granted Apr 8, 2014·13 cites·14 claims
- 0378US9416169B2Humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2015·Granted Aug 16, 2016·2 cites·18 claims
- 0477US12319970B2Methods for identifying progression of a primary melanomaBRIGHAM & WOMENS HOSPITAL INC·Filed 2022·Granted Jun 3, 2025·0 cites·7 claims
- 0574US8962806B2Humanized monoclonal antibodies and methods of useMARASCO WAYNE·Filed 2008·Granted Feb 24, 2015·3 cites·13 claims
- 0668US6929792B1Modified dendritic cells and use thereforCBR INST FOR BIOMED RES INC·Filed 2000·Granted Aug 16, 2005·3 cites·16 claims
- 0763US9416371B2T-cell vaccination with viral vectors via mechanical epidermal disruptionTREMRX INC·Filed 2014·Granted Aug 16, 2016·1 cites·13 claims
- 0862US2023364227A1Poxvirus adjuvant for t-cell vaccinationPELLIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0960US2018094064A1Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 1060US2019276544A1Affinity matured anti-ccr4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 1159US2020318200A1Methods for Identifying Progression of a Primary MelanomaBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
- 1258US9587028B2Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2015·Granted Mar 7, 2017·0 cites·6 claims
- 1355US10584172B2Humanized monoclonal antibodies and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Mar 10, 2020·0 cites·5 claims
- 1449US7402432B2Process for producing T lymphocytesBRIGHAM & WOMENS HOSPITAL·Filed 2004·Granted Jul 22, 2008·0 cites·26 claims
- 1537US9629910B2Use of Th9 cells and IL-9 for the treatment of melanomaKUPPER THOMAS S·Filed 2012·Granted Apr 25, 2017·0 cites·4 claims
- 1637US2020375965A1Targeting Lipid Metabolism and Free Fatty Acid (FFA) Oxidation to Treat Diseases Mediated by Resident Memory T Cells (TRM)BRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Application pending·0 cites
- 1736US2015218656A1Methods for detection and diagnosis of a lymphoid malignancy using high throughput sequencingADAPTIVE BIOTECHNOLOGIES CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas S. Kupper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →